Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments. We have a well-established commercial presence in Europe and are focused on the US market. We specialise in the diagnosis and treatment of allergy. We mainly sell our products in European countries and our pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, as well as a peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside of allergy are also under evaluation.
View Top Employees from Allergy TherapeuticsWebsite | http://www.allergytherapeutics.com/ |
Ticker | AGY |
Revenue | $96 million |
Employees | 380 (318 on RocketReach) |
Founded | 1998 |
Phone | +44 1903 844700 |
Fax | +44 1903 844726 |
Technologies |
HTML,
reCAPTCHA,
ASP.NET
+24 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Health Care, Healthcare, Health Diagnostics, Drug Discovery, Medical |
Web Rank | 3 Million |
Keywords | Allergen Immunotherapy |
Competitors | Biological E limited, HIPRA, IDT Biologika, Ipsen, Panacea Biotec |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54138 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5413 Companies |
Looking for a particular Allergy Therapeutics employee's phone or email?
The Allergy Therapeutics annual revenue was $96 million in 2024.
Nick Wykeman is the CFO of Allergy Therapeutics.
318 people are employed at Allergy Therapeutics.
The NAICS codes for Allergy Therapeutics are [54138, 541, 54, 5413].
The SIC codes for Allergy Therapeutics are [28, 283].